Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Medincell SA banner

Medincell SA
PAR:MEDCL

Watchlist Manager
Medincell SA Logo
Medincell SA
PAR:MEDCL
Watchlist
Price: 22.34 EUR 3.43% Market Closed
Market Cap: €802.2m
Write Note Create Alert Ask AI

Wall St Price Targets

MEDCL Price Targets Summary
Medincell SA

Wall Street analysts forecast MEDCL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDCL is 33.66 EUR with a low forecast of 23.33 EUR and a high forecast of 40.95 EUR.

MEDCL Lowest Forecast
Wall Street Target
€23.33
4% Upside
MEDCL Average Forecast
Wall Street Target
€33.66
51% Upside
MEDCL Highest Forecast
Wall Street Target
€40.95
83% Upside
Lowest Forecast
Price Target
23.33 EUR
4% Upside
Average Forecast
Price Target
33.66 EUR
51% Upside
Highest Forecast
Price Target
40.95 EUR
83% Upside
Medincell SA Competitors:
Price Targets

Revenue
Forecast

61% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-40%
Average Miss
61% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-40%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 61%. The projected CAGR for the next 8 years is 34%.

What are analyst estimates?

Gross Profit
Forecast

96% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-53%
Average Miss
96% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-53%
Average Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been 96%. The projected CAGR for the next 4 years is 44%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
37%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
37%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

What are analyst estimates?

Continue MEDCL Research

Summary
MEDCL intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDCL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDCL stock valuation using valuation multiples.
Wall St Estimates
MEDCL price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDCL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Medincell SA listings:
OTC • USD
MDCLF
 F • EUR
MEB
 LSE • EUR
0ACH
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MEDCL's stock price target?
Price Target
33.66 EUR

According to Wall Street analysts, the average 1-year price target for MEDCL is 33.66 EUR with a low forecast of 23.33 EUR and a high forecast of 40.95 EUR.

What is the Revenue forecast for Medincell SA?
Projected CAGR
34%

Over the last 6 years, the compound annual growth rate for Revenue has been 61%. The projected CAGR for the next 8 years is 34%.

What is the Gross Profit forecast for Medincell SA?
Projected CAGR
44%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 96%. The projected CAGR for the next 4 years is 44%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.